Marek David C 4
4 · Axsome Therapeutics, Inc. · Filed Mar 19, 2020
Insider Transaction Report
Form 4
Marek David C
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-03-17+53,984→ 53,984 totalExercise: $45.14Exp: 2030-03-16→ Common Stock (53,984 underlying) - Award
Restricted Stock Units
2020-03-17+16,533→ 16,533 total→ Common Stock (16,533 underlying)
Footnotes (3)
- [F1]The option will vest in substantially equal quarterly installments over four years such that the option will be fully vested on March 17, 2024.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F3]25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in in three substantially equal annual installments, such that the RSUs will be fully vested on March 17, 2024. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's 2015 Omnibus Incentive Compensation Plan (the "Plan"), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant.